← Search

Omics · study · 2026

GLI2 mediates response to paclitaxel in triple-negative breast cancer

Listed in NCBI GEO

Bone is the most frequent site of both metastasis and recurrence for patients with breast cancer, and there are currently no FDA-approved therapeutics which target cancer in bone.

Description

Skeletal metastases upregulate the transcription factor Glioma-associated oncogene 2 (Gli2), resulting in secretion of parathyroid hormone-related protein (PTHrP), which accelerates bone turnover and enables tumor proliferation. Gli2 has been implicated as a mediator of chemoresistance in a wide range of cancers, but its unique role in drug resistance has yet to be defined in treatment-resistant skeletal metastases.

Therefore, this dataset aims to define the impact of GLI2 CRISPR knockout on transcriptional response to paclitaxel (PTX), the current standard of care for breast cancer patients with distant metastases.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 75%
Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE30216814 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title